Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

255
The pathophysiology of pneumonia involves the following steps:
255
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

200
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Pulmonary Inflammation And Viral Replication Define Distinct Clinical Outcomes In Fatal Cases Of Covid-19

Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19

Keyla S G de Sá1, Luana A Amaral1, Tamara S Rodrigues1

  • 1Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.

Plos Pathogens
|June 5, 2024

Related Experiment Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.1K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.2K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.1K

View abstract on PubMed

Summary
This summary is machine-generated.

Severe COVID-19 outcomes are linked to inflammasome activation and viral load. Two patient clusters show distinct profiles, influencing disease severity and treatment strategies for lethal SARS-CoV-2 infections.

Area of Science:

  • Immunology
  • Pathology
  • Virology

Background:

  • COVID-19 has caused millions of deaths globally, yet mechanisms of lethal disease and factors influencing outcomes remain unclear.
  • Understanding host determinants is crucial for developing effective treatments for severe SARS-CoV-2 infections.

Purpose of the Study:

  • To investigate pathophysiological mechanisms in lethal COVID-19 cases.
  • To correlate lung inflammation, viral load, and inflammasome activation with clinical and histopathological findings.
  • To identify distinct patient profiles in severe COVID-19.

Main Methods:

  • Analysis of lung autopsies from 47 COVID-19 patients.
  • Assessment of inflammatory profiles, viral loads, and inflammasome activation (NLRP3).
  • Gene expression analysis to classify patients and experiments in Nlrp3 knockout mice.

Related Experiment Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.1K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.2K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.1K

Main Results:

  • Robust inflammasome activation was observed in lethal COVID-19 cases.
  • Nlrp3 knockout mice showed protection against SARS-CoV-2-induced disease.
  • Two patient clusters were identified: Cluster 1 (higher viral load, lower inflammation) and Cluster 2 (lower viral load, higher inflammation).
  • Significant differences were noted between clusters in illness duration, ventilation needs, fibrosis, and thrombosis.

Conclusions:

  • Lethal COVID-19 cases exhibit two distinct profiles driven by the balance between viral replication and inflammasome-mediated inflammation.
  • Inflammasome activation, particularly NLRP3, plays a significant role in COVID-19 exacerbation.
  • These findings are critical for guiding therapeutic decisions between immune-mediated and antiviral strategies in critical COVID-19 cases.